 |
Somatropin for injection |
|---|---|
| Trade Name | Humatrope |
| Orphan Indication | For the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone |
| USA Market Approval | USA |
| USA Designation Date | 1986-06-12 00:00:00 |
| Sponsor | Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 |
